Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 1,417 | 6,045 | 8,189 | 7,622 | 7,031 |
| Gross Profit | 1,417 | 6,045 | 8,189 | 7,622 | 7,031 |
| Operating Expenses | 31,412 | 26,590 | 27,881 | 26,814 | 24,214 |
| Operating Income | -29,995 | -20,545 | -19,692 | -19,192 | -17,183 |
| Interest Expense | 730 | 719 | 716 | 0 | 0 |
| Other Income | 445 | 550 | 527 | 414 | 774 |
| Pre-tax Income | -30,280 | -20,714 | -19,881 | -18,778 | -16,409 |
| Net Income Continuous | -30,280 | -20,714 | -19,881 | -18,778 | -16,409 |
| Net Income | $-30,280 | $-20,714 | $-19,881 | $-18,778 | $-16,409 |
| EPS Basic Total Ops | -7.20 | -5.60 | -5.60 | -3.60 | -4.60 |
| EPS Basic Continuous Ops | -7.25 | -5.65 | -5.61 | -3.49 | -4.69 |
| EPS Diluted Total Ops | -7.20 | -5.60 | -5.60 | -3.60 | -4.60 |
| EPS Diluted Continuous Ops | -7.25 | -5.65 | -5.61 | -3.49 | -4.69 |
| EBITDA(a) | $-28,422 | $-18,890 | $-17,956 | $-17,196 | $-15,394 |